By MATTHEW GOLDSTEIN
As defenses go, it was an odd one. The hedge fund investor said he expected the drug maker to be investigated by regulators and prosecutors for years.
Published: October 31, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1kgRBXg
from WordPress http://ift.tt/1kgTd3c
via Hadi Aboukhater
No comments:
Post a Comment